openPR Logo
Press release

What's driving the Thalassemia Market growth? Key Players are ApoPharma Inc., Novartis, Teva Pharmaceuticals, Fresenius Kabi, Pfizer, bluebird bio, Acceleron Pharma, Incyte, Celgene, GSK, Vifor Pharma, Lonza, La Jolla Pharmaceutical Company and others

05-06-2019 11:53 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Thalassemia Market Outlook, Trend, Share, Size, Application, Growth and Forecast

Global Thalassemia Market Outlook, Trend, Share, Size, Application, Growth and Forecast

The Thalassemia market report comprises of the most recent market information with which companies can have in depth analysis of Pharmaceutical industry and future trends. By applying market intelligence for this report, industry experts assess strategic options, outline successful action plans and support companies with critical bottom-line decisions. Competitive analysis studies of this market report helps to get ideas about the strategies of key players in the market. Not to mention, the scope of this market report can be broadened from market scenarios to comparative pricing between major players, cost and profit of the specified market regions.

Thalassemia market research report lends a hand to business in every sphere of trade to take first-class decisions, to tackle the toughest business questions and reduce the risk of failure. The important highlights of Thalassemia market report are key market dynamics, current market scenario and future prospects of the sector. Thalassemia market research report is an absolute overview of the market that spans various aspects such as product definition, customary vendor landscape, and market segmentation based on various parameters such as type of product, its components, type of management and geography.

Global Thalassemia Market is expected to rise from its initial estimated value of USD 1.99 billion to a projected value of USD 4.36 billion by 2026, registering a CAGR of 10.29% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing concern and awareness regarding the disease globally.

Download FREE | Sample Report at https://databridgemarketresearch.com/request-a-sample/?dbmr=global-thalassemia-market

Key Market Competitors: Global Thalassemia Market

ApoPharma Inc., Novartis, Teva Pharmaceuticals, Fresenius Kabi, Pfizer, bluebird bio, Acceleron Pharma, Incyte, Celgene, GSK, Vifor Pharma, Lonza, La Jolla Pharmaceutical Company, Ionis Pharmaceuticals, Inc., Kiadis Pharma, Gamida Cell Ltd., Sangamo Therapeutics, Inc.
Market Drivers

Increasing prevalence of the disease globally without any viable treatment options available for curing the disease; this factor is expected to drive the market growth

Growth in development of pipeline drugs and development of new therapies because of R&D activities and investments by the various authorities; this factor is expected to drive the market growth

Market Restraint

Lack of viable treatment options commercialized for the treatment of disease/disorder rather than the symptoms associated with the disease; this factor is expected to restrain the market growth

High cost of treatment for the disorder is expected to act as a restraint to the market growth

Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team (sopan.gedam@databridgemarketresearch.com), who will ensure that you get a report that suits your needs.

Table of Content

Chapter 1 Methodology & Scope

1.1 Methodology

Initial data exploration

Statistical model and forecast

Industry insights and validation

Definition and forecast parameters

1.2 Data Sources

Secondary

Primary

Chapter 2 Executive Summary

2.1 Thalassemia industry 360 degree synopsis, 2019 - 2026

Regional trends

Solution trends

Chapter 3 Thalassemia Industry Insights

Industry segmentation

Industry landscape, 2019 - 2026

Industry ecosystem analysis
Industry participant analysis

Major pain points

Industry impact forces

Growth drivers

Technological advancements

Emerging trend across E-Commerce industry

Industry pitfalls and challenges

Lack of logistics control

Growth potential analysis

Porter's analysis

Company market share analysis, 2016

3.9.1 Overview of key players

Development of competitive positioning over time

PESTEL analysis

Chapter 4 Thalassemia Market, By Solution

4.1 Thalassemia market share by Application, 2016 & 2024

Market estimates and forecast, by region, 2019 - 2026 (USD Billion) … And Continue… Ask For FREE TOC

Download FREE | TOC At https://databridgemarketresearch.com/toc/?dbmr=global-thalassemia-market

Segmentation: Global Thalassemia Market

By Thalassemia Type

Alpha Thalassemia
Beta Thalassemia

By Therapeutic Class

Iron Chelating Drugs
Exjade/Jadenu (deferasirox)

By Pipeline

Gene Therapy
LentiGlobin

By End-User

Hospitals
Clinics
Research Institutes
Laboratories

By Geography

North America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Market:

In April 2019, CELGENE CORPORATION and Acceleron Pharma, Inc. announced that CELGENE had submitted a Biologics License Application (BLA) for “luspatercept” with the U.S. F.D.A. (United States Food & Drug Administration). This will help in faster commercialization and development of drugs for patients suffering from blood diseases.

In January 2019, Vifor Pharma announced positive results from their phase-I trial of “VIT-2763” an oral ferroportin inhibitor. The drug being developed for transportation of iron from one cell to another has shown signs in reduction of serum iron in a dose-dependent state.

Competitive Analysis: Global Thalassemia Market

Global thalassemia market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of thalassemia market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report

Current and future of global thalassemia market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

Speak to The Author at https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-thalassemia-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What's driving the Thalassemia Market growth? Key Players are ApoPharma Inc., Novartis, Teva Pharmaceuticals, Fresenius Kabi, Pfizer, bluebird bio, Acceleron Pharma, Incyte, Celgene, GSK, Vifor Pharma, Lonza, La Jolla Pharmaceutical Company and others here

News-ID: 1728119 • Views: 564

More Releases from Data Bridge Market Research

Global Aluminum Systems Market Size, Share, Trends, Business Strategy To 2026 | …
Global Aluminum Systems Market is expected to rise from its initial estimated value of USD 134.1 billion in 2018 to an estimated value of USD 213.7 billion by 2026, registering a CAGR of 6% in the forecast period of 2019-2026. This rise of market value can be attributed to the rising technological advancements in the market. The Aluminum Systems market report covers the competitive scenario of the primary players operating in
Global Refrigerant Market 2025: Growth, Emerging Trends And Forecast By Arkema S …
Global Refrigerant Market is expected to reach 2,019.96 Thousand Metric Tons by 2025 from 1,306.44 Thousand Metric Tons in 2017, at a CAGR of 5.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025. The Refrigerant market research report offers an in-depth analysis of the global market size
Global Disseminated Intravascular Coagulation (DIC) Market Future Forecast Repor …
The most appropriate, exclusive, realistic and admirable market research report is delivered with devotion depending upon your business needs. With the precise base year and the historic year, estimations and calculations are performed in this Global Disseminated Intravascular Coagulation (DIC) Market report. Market share analysis and key trend analysis are the key accomplishing factors in this Global Disseminated Intravascular Coagulation (DIC) Market report. Report helps you recognize how the market
Global Hepatic Antiviral Drugs Market 2020 Future Growth with Top Players Teva P …
Global Hepatic Antiviral Drugs Market report makes available an overview of the industry which is gaining momentum in the last few years. The market report uses a range of steps for collecting, recording, analysing and interpreting market data to make this report all-inclusive. It also offers an outline of the industry that might promote interest among prospective investors, large corporations and everyday users who could participate in the next big

All 5 Releases


More Releases for Thalassemia

Thalassemia Treatment Market is driven by increase in number of altered thalasse …
Thalassemia Treatment Market - Snapshot The global thalassemia treatment market is driven by increase in number of altered thalassemia genes across the globe. The global market was valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026 to reach US$ 1,639.6 Mn by 2026. The global market is witnessing high growth owing to increase in blood transfusion and chelation therapy
Alpha Thalassemia Market Import | Export Outlook and Global Foresight 2023
Report Description This report analyzes the alpha thalassemia market by type (hb bart syndrome, hbh disease, silent carrier state, and trait.), by diagnosis (perinatal testing, prenatal testing, and pre-implantation), by treatment, by end user; it also studies the top manufacturers in the market. The alpha thalassemia market is expected to grow at a CAGR of approximately 8.8% during the forecast period 2017-2023. GET SAMPLE REPORT @ https://www.wiseguyreports.com/reports/3365840-alpha-thalassemia-market-research-report-global-forecast-till-2023 The major players in
Global Thalassemia Market Demand, Growth, Opportunities and Analysis By 2021
SUMMARY WiseGuyReports published new report, “Global Thalassemia Market” Thalassemia is a blood disorder that causes abnormal production of hemoglobin in an affected person. It is a genetic disorder inherited from parents. Hemoglobin carries oxygen in the blood and is produced by two proteins called alpha globin and beta globin. A person inherits four genes to produce alpha globin protein and two genes to produce alpha globin protein from parents. Thalassemia is caused
Analytical insights about Beta Thalassemia Testing Market Provided in Detail
Beta thalassemia can be simplified as a diseased state of blood in which there is reduced hemoglobin production. Hemoglobin is a protein containing iron and is present in Red blood cells and the major function of hemoglobin is to carry oxygen to the body cells throughout the body. Low hemoglobin content in the beta thalassemia patients usually leads to the lack of oxygen in many parts of the body. Due
Thalassemia - Pipeline Review, H2 2017
Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H2 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms include fussiness, paleness, frequent infections, failure to thrive, poor appetite and jaundice. Predisposing factors include family history. Treatment includes blood transfusions and bone marrow
Thalassemia - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Thalassemia - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H1 2017, provides an overview of the Thalassemia (Hematological Disorders) pipeline landscape. Thalassemia is a group of inherited blood disorders that affect the body's ability to produce hemoglobin and red blood cells. Symptoms